BATTAGLIA, MARIO ALBERTO
 Distribuzione geografica
Continente #
EU - Europa 18.241
NA - Nord America 17.147
AS - Asia 9.734
SA - Sud America 1.636
AF - Africa 461
OC - Oceania 65
Continente sconosciuto - Info sul continente non disponibili 20
Totale 47.304
Nazione #
US - Stati Uniti d'America 16.864
GB - Regno Unito 5.286
SG - Singapore 3.532
IT - Italia 3.152
CN - Cina 2.875
RU - Federazione Russa 2.861
IE - Irlanda 2.039
BR - Brasile 1.363
UA - Ucraina 1.212
FR - Francia 1.024
VN - Vietnam 936
DE - Germania 786
SE - Svezia 776
HK - Hong Kong 766
FI - Finlandia 443
KR - Corea 393
TR - Turchia 276
IN - India 233
NL - Olanda 196
BD - Bangladesh 161
CA - Canada 134
ZA - Sudafrica 133
NG - Nigeria 112
ES - Italia 96
MX - Messico 87
AR - Argentina 86
AT - Austria 84
IQ - Iraq 73
CI - Costa d'Avorio 66
PL - Polonia 60
AU - Australia 58
JP - Giappone 57
BE - Belgio 48
ID - Indonesia 48
IR - Iran 46
EC - Ecuador 40
SA - Arabia Saudita 40
PK - Pakistan 38
MY - Malesia 37
IL - Israele 35
KE - Kenya 35
CL - Cile 30
VE - Venezuela 28
CO - Colombia 27
MA - Marocco 26
CH - Svizzera 22
AE - Emirati Arabi Uniti 21
GR - Grecia 21
LT - Lituania 21
PH - Filippine 20
PY - Paraguay 20
RO - Romania 18
DZ - Algeria 17
JO - Giordania 17
UY - Uruguay 17
EG - Egitto 16
UZ - Uzbekistan 16
JM - Giamaica 15
PT - Portogallo 15
EU - Europa 14
NP - Nepal 14
ET - Etiopia 13
KZ - Kazakistan 13
PE - Perù 13
TN - Tunisia 13
AZ - Azerbaigian 12
AL - Albania 10
BO - Bolivia 9
CZ - Repubblica Ceca 9
OM - Oman 9
SN - Senegal 9
CR - Costa Rica 7
LB - Libano 7
LK - Sri Lanka 7
MN - Mongolia 7
RS - Serbia 7
GT - Guatemala 6
KG - Kirghizistan 6
PS - Palestinian Territory 6
BG - Bulgaria 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
EE - Estonia 5
HN - Honduras 5
LV - Lettonia 5
MD - Moldavia 5
MK - Macedonia 5
NZ - Nuova Zelanda 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BH - Bahrain 4
PA - Panama 4
SY - Repubblica araba siriana 4
AM - Armenia 3
AO - Angola 3
BS - Bahamas 3
GY - Guiana 3
HR - Croazia 3
Totale 47.235
Città #
Southend 4.931
Dallas 2.017
Dublin 2.007
Singapore 1.975
Chandler 1.329
Fairfield 1.308
Ashburn 1.077
Jacksonville 1.052
Hong Kong 735
Santa Clara 685
Wilmington 661
Beijing 633
Woodbridge 621
Moscow 597
Houston 505
Seattle 505
San Jose 484
Princeton 481
Hefei 446
Cambridge 407
Ann Arbor 399
Seoul 381
The Dalles 381
Nanjing 327
Los Angeles 278
Siena 276
Dong Ket 272
Helsinki 267
Lauterbourg 250
Munich 244
Milan 229
Boardman 218
Council Bluffs 214
Ho Chi Minh City 208
New York 185
Rome 181
Hanoi 168
San Mateo 156
Buffalo 141
Menlo Park 124
São Paulo 112
Nanchang 109
Istanbul 104
Abuja 102
Johannesburg 101
Florence 99
San Diego 98
Orem 87
Redondo Beach 85
Chicago 79
Shenyang 79
Izmir 76
Abidjan 66
Tianjin 66
Vienna 63
Changsha 62
Shanghai 59
Bengaluru 56
Hebei 56
Toronto 56
Amsterdam 55
Columbus 55
Jiaxing 53
Naples 52
London 51
Norwalk 51
Frankfurt am Main 50
Rio de Janeiro 49
San Francisco 48
Chennai 47
Tokyo 47
Kunming 46
Nuremberg 46
Dearborn 45
Venezia 45
Düsseldorf 44
Warsaw 44
Palermo 43
Guangzhou 38
Washington 36
Belo Horizonte 32
Bologna 31
Hangzhou 30
Jinan 30
Málaga 30
Phoenix 30
Atlanta 29
Fremont 29
Lappeenranta 29
Manchester 29
Campinas 28
Jesi 28
Brussels 27
Da Nang 27
Haiphong 27
Montreal 27
Brooklyn 26
Catania 26
Dhaka 26
Agrigento 25
Totale 30.481
Nome #
Level of Activity in Profound/Severe Mental Retardation (LAPMER): a Rasch-derived scale of disability 1.506
New insights into the burden and costs of multiple sclerosis in Europe 625
Mam36 and Abilhand as outcome measures of multiple sclerosis hand disability: an observational study 605
Incidenza della sclerosi multipla in Toscana: uno studio basato su dati amministrativi 461
Adaptive vs. non-adaptive cognitive training by means of a personalized App: a randomized trial in people with multiple sclerosis 396
A study on hot-beverages vending machines: what do we daily drink? 394
Stima della prevalenza della sclerosi multipla in Italia nel 2013 375
A short measure of balance in multiple sclerosis: validation through Rasch analysis 327
Multiple sclerosis incidence in Tuscany from administrative data 298
Analisi dei percorsi diagnostico terapeutico assistenziali (PDTA) regionali sulla sclerosi multipla esistenti 295
Transforming multiple sclerosis care in Italy through Integrated Care Pathways and local networks of service providers. A survey on clinical centres 288
Automatic Vending-Machines Contamination: A Pilot Study 285
Estimated prevalence of multiple sclerosis in Italy in 2015 284
Multiple sclerosis spatial cluster in Tuscany 272
A new app for at-home cognitive training: description and pilot testing on patients with multiple sclerosis 267
Multiple sclerosis incidence in Tuscany from administrative data 264
Economic impact of multiple sclerosis in Italy: focus on rehabilitation costs 262
Chlorination by-products (CBPs) in drinking water and adverse pregnancy outcomes in Italy 259
EAN Guideline on Palliative Care of People with Severe, Progressive Multiple Sclerosis 259
Incidenza della sclerosi multipla in Toscana: uno studio basato sui dati amministrativi 255
Participant perspectives of a home-based palliative approach for people with severe multiple sclerosis: A qualitative study 253
Unmet care needs of people with a neurological chronic disease: A cross-sectional study in Italy on Multiple Sclerosis 252
Presenting evidence-based health information for people with multiple sclerosis: the IN-DEEP project protocol 252
I registri come importante fonte di real world data: l’esperienza del Registro Italiano Sclerosi Multipla e Patologie Correlate [Registers as central real world data source: the experience of the Italian Multiple Sclerosis and Related Disorders Register] 250
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 250
Brain activity pattern changes after adaptative working memory training in multiple sclerosis 246
Complessità terapeutico-assistenziale e management della sclerosi multipla: utilizzo di indicatori basati sul dato amministrativo 245
Unmet needs of people with severe multiple sclerosis and their carers: Qualitative findings for a home-based intervention 245
Prevalence of multiple sclerosis in tuscany (central Italy): a study based on validated administrative data 241
Multiple sclerosis epidemiology in Europe 240
The Italian Multiple Sclerosis Register 239
Increasing prevalence of multiple sclerosis in Tuscany, Italy 238
Antiepileptic medications in multiple sclerosis: adverse effects in a three-year follow-up study 237
Azathioprine versus beta interferons for relapsing-remitting multiple sclerosis: A multicentre randomized non-inferiority trial 236
Economic impact of multiple sclerosis in 2011 in Italy. Focus on rehabilitation costs 236
Incidenza della sclerosi multipla in Toscana: uno studio basato su dati amministrativi 234
Mortality trend for multiple sclerosis in Italy during the period 1980–2015 231
Prevalence of multiple sclerosis in Tuscany at 2011: a study based on validated administrative data 228
Increasing prevalence of multiple sclerosis in Tuscany: a study based on validated administrative data 223
La distribuzione geografica della sclerosi multipla in Toscana 222
An interdisciplinary approach to evaluating the need for assistive technology reduces equipment abandonment 222
Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis 221
Randomized controlled trial of a home-based palliative approach for people with severe multiple sclerosis 219
Self-assessment reliability in multiple sclerosis: the role of socio-demographic, clinical and quality of life aspects 216
Workers with disability: the case of multiple sclerosis 214
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy 213
Active smoking and environmental tobacco smoke (ets) exposure in pregnancy and preterm/very preterm delivery: a multicentric Italian study 212
A randomized placebo-controlled cross-over study using a low frequency magnetic field in the tratment of fatigue in multiple sclerosis 211
Multiple sclerosis in Italy: cost-of-illness study 211
Has the italian law ‘‘save suicide’’ had effect? 208
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it? 206
Analysis of met and unmet needs for people with MS 206
Increasing prevalence of multiple sclerosis in Tuscany: a study based on validated administrative data 206
Multiple sclerosis registries in Europe – An updated mapping survey 205
Assessing the health research’s social impact: a systematic review 204
A new tool to evaluate superior arm movement in multiple sclerosis subjects during rehabilitation 204
La riabilitazione in Italia per la sclerosi multipla 203
HTLV I e HTLV II nelle malattie neurologiche 202
Multiple sclerosis registries in Europe - Results of a systematic survey 202
Prevalence of multiple sclerosis in Tuscany: a study based on administrative data 201
Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis 201
The costs of multiple sclerosis: a cross-sectional, multicenter cost-of-illness study in Italy 199
User testing as a method for evaluating subjects’ understanding of informed consent in clinical trials in multiple sclerosis 199
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register 198
The prevalence of multiple sclerosis in the north-west Italian province of Genoa 197
Tailored balance exercises on people with multiple sclerosis: A pilot randomized, controlled study 197
Fattori che influenzano lo stato di occupazione delle persone con una disabilità: il caso della Sclerosi Multipla 196
Adaptive versus non-adaptive cognitive rehabilitation training based on working memory: effects on people with multiple sclerosis 195
Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study 194
Motor imagery as a function of disease severity in multiple sclerosis: An fMRI study 194
The prevalence of multiple sclerosis on the island of Elba 193
Patients with multiple sclerosis: a burden and cost of illness study 191
Tailored balance exercises for people with multiple sclerosis: a pilot randomized controlled study 191
The SMile Card: a computerised data card for multiple sclerosis patients 190
Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): rationale, design, and methodology 190
Upper limb motor rehabilitation impacts white matter microstructure in multiple sclerosis 190
Esposizione prenatale ai policlorobifenili (PCB): analisi della placenta, del cordone e del sangue del cordone 190
La sorveglianza della poliomielite in Italia: stato immunitario della popolazione di età 0-14 anni: TOSCANA 189
I fattori che precludono il lavoro alle persone con Sclerosi Multipla 189
Rethinking MS in Europe: Prioritising Timely, Integrated Care for People with Multiple Sclerosis 188
Registro toscano e sclerosi multipla: dati preliminari 186
Esposizione prenatale ai contaminanti organoclorurati (PCB): concentrazione nel tessuto placentare, cordone ombelicale e sangue del cordone 186
Resting-state functional connectivity and motor imagery brain activation 185
The changing face of multiple sclerosis: Prevalence and incidence in an aging population 185
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 185
Patient and caregiver involvement in formulation of guideline questions: Findings from the EAN Guideline on Palliative Care of People with Severe Multiple Sclerosis 184
Prevalence of oedema of the lower limbs in multiple sclerosis patients: a vascular and lymphoscintigraphic study 184
Caregiver quality of life in multiple sclerosis: a multicentre Italian study 183
Steps towards Collective Sustainability in Biomedical Research 183
Effectiveness of in-home speech therapy for MS patients with severe disability 183
I servizi di riabilitazione per la sclerosi multipla nell'Unione Europea allargata 183
A cost evaluation of multiple sclerosis 182
Preterm delivery and exposure to active and passive smoking during pregnancy: a case-control study from Italy 182
Multiple sclerosis and rehabilitation: an overview of the different rehabilitation settings 181
Epidemiological socio-health study of multiple sclerosis in Italy 180
Il costo sociale della sclerosi multipla in Italia: focus sulla riabilitazione 179
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies 178
Setting the standards, evaluating and implementing health service quality 176
MSIF Atlas of MS database update: multiple sclerosis resources in the world 2013 176
New insights into the burden and costs of multiple sclerosis in Europe: results for Italy 176
Totale 24.469
Categoria #
all - tutte 143.473
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 143.473


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021487 0 0 0 0 0 0 0 0 0 0 0 487
2021/20223.745 211 328 264 261 194 106 114 156 204 374 337 1.196
2022/20234.384 285 300 543 633 500 896 61 372 486 82 133 93
2023/20243.073 141 91 288 137 111 830 931 111 12 73 100 248
2024/20257.084 195 465 513 424 618 389 379 512 592 351 769 1.877
2025/202614.814 1.130 2.171 1.596 1.405 2.793 649 1.895 646 690 948 637 254
Totale 48.256